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Abstract
Brevetoxin A is a decacyclic ladder toxin that possesses five-,six-, seven-, eight-, and nine-membered
oxacycles, as well as 22 tetrahedral stereocenters. Herein, we describe a unified approach to the B,
E, G, and J rings predicated upon a ring-closing metathesis strategy from the corresponding dienes.
The enolate technologies developed in our laboratory allowed access to the precursor acyclic dienes
for the B, E, and G medium ring ethers. The strategies developed for the syntheses of these four
monocycles ultimately provided multigram quantities of each of the rings, supporting our efforts
toward the convergent completion of brevetoxin A.
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Introduction
The marine ecosystem is a source of a multitude of structurally and biologically fascinating
molecular metabolites, of which the ladder ether toxins are some of the most complex and
intriguing small molecules ever discovered. The exquisite structures of marine polycyclic ether
natural products, which characteristically contain a linear series of trans-fused ether rings of
varying sizes from five to nine members with assorted methyl and hydroxyl substituents
appended, have captured the imagination of synthetic chemists for over two decades. The
development of novel technologies and strategies for the preparation of ladder toxin natural
products has driven the total syntheses of a number of these targets.[1] As a representative
member of this class, the structure of brevetoxin A (1), which was first elucidated in 1986 by
Shimizu and co-workers[2a,b] through X-ray analysis and independently by Nakanishi through
spectroscopic studies,[2c] features ten rings (including five-, six-, seven-, eight, and nine-
membered oxacycles) fused in a linear array containing 22 tetrahedral stereocenters.
Brevetoxin A is a highly toxic metabolite of Karenia brevis, which is known to cause the
infamous red tide phenomenon responsible for massive fish kills as well as neurotoxic shellfish
poisoning and bronchial irritation in humans.[3] The bioactivity of brevetoxin A is attributed
to strong binding to the α subunit of the voltage-sensitive sodium ion channels, effecting an
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increase in the mean channel open time and inhibiting channel inactivation.[3a] The landmark
total synthesis reported in 1998 by Nicolaou[4] stands as the only completed synthesis of this
captivating target.
A fundamental goal in our vision for the total synthesis of brevetoxin A (1) was the
incorporation of maximum convergency, particularly in three major disconnections. The first
disconnection directed the simplification of the natural product into two tetracyclic halves of
similar complexity (2 and 3), which would be united in a stereoselective Horner–Wittig reaction
precedented by the previous synthesis by Nicolaou (Scheme 1). [4,5] The Horner–Wittig
coupling partners 2 and 3 would be obtained from advanced fragments 4 and 5 respectively,
which would be further disconnected into two subunits each. Specfically, the the BCDE
fragment 4[6a] would be prepared from the B and E ring subunits 6 and 7 through a novel
convergent [X + 2 + X] strategy,[1c] and the GHIJ subunit 5[6b] would be prepared in an
analogous way from the G and J ring subunits 8 and 9. The adjoining manuscript details the
convergent [X + 2 + X] strategy, as well as the versatile endgame approach which ultimately
led to the completed total synthesis of brevetoxin A.[7] Described herein is the development
of scalable routes to the four ring subunits 6-9, which were prepared via ring-closing metathesis
[8] from acyclic diene precursors with stereodefined α-carbons in the ether linkage. In the case
of the B, E and G rings, the stereogenicity of the α-carbons would be established through the
implementation of enolate technology developed in our laboratory.
Results and Discussion
Synthesis of the B Ring
Efforts toward the total synthesis of brevetoxin A (1) commenced with the initial goal of
preparing three of the four medium ring ethers present in the natural product, namely the B, E,
and G rings. At the outset, the B ring 10 was targeted for assembly via a glycolate alkylation
strategy to set the stereogenic centers of the ether linkage,[9] followed by ring-closing
metathesis and hydrogenation to create the oxocane (Figure 1).[10]
A Sharpless asymmetric epoxidation[11] of 1,4-pentadien-3-ol (12) conveniently provided an
epoxide 13 as a chiral starting material, and the secondary alcohol of the epoxide was protected
as a benzyl ether to give the known epoxy ether 14 in 91% yield (Scheme 2). The epoxide
14 was opened at its terminus with cyanide ion, and the resultant nitrile was transformed to the
diol 15 by hydrolysis of the nitrile and reduction of the resulting acid. The primary alcohol was
selectively protected as its TIPS ether and the secondary alcohol was alkylated with sodium
bromoacetate to produce a glycolic acid, which was converted to its mixed anhydride. The
mixed anhydride of the glycolic acid was utilized to acylate (R)-lithio-4-isopropyl-2-
oxazolidinone, providing glycolyl oxazolidinone 11 and staging an alkylation to
stereoselectively install the C9 substituent.[9] In the event, alkylation of the sodium enolate of
glycolate 12 with iodide 16 afforded an 80% yield of diene 17 as a single detectable
diastereomer by 1H NMR. Reductive removal of the auxiliary, oxidation[12] of the resultant
alcohol to the aldehyde, and Brown asymmetric allylation[13] of the aldehyde provided
stereodefined triene 18 in 90% yield for the three step sequence. Protection of the secondary
alcohol as an acetate ester and oxidative removal of the p-methoxybenzyl ether preceded a
Sharpless asymmetric epoxidation[b] to provide diene 19 in high yield. Ring-closing metathesis
was attempted using diene 19 in the presence of the Grubbs second generation catalyst
[Cl2(Cy3P)(sIMes)Ru=CHPh],[8a,b] but the desired oxocene was not observed.[14] Aware of
precedent involving the facilitation of medium ring synthesis via ring-closing metathesis using
cyclic constraints,[15] we chose to install a tetrahydrofuran as a temporary cyclic constraint.
Base-induced cleavage of the acetate of diene 19 led to spontaneous cyclization to form a
tetrahydrofuran, and the resultant 1,2-diol was oxidatively cleaved to provide an aldehyde that
was reduced to afford alcohol 20.[16] Gratifyingly, treatment of diene 20 with the Grubbs
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second generation catalyst in refluxing dichloromethane for three days provided the targeted
oxocene 21 in 70% yield, along with 14% of the recovered diene 20.[17]
With this encouraging result, we set out to examine the stereoselective introduction of the C8
methyl stereocenter. Oxazolidinone 17 was converted in four straight-forward steps to methyl
ketone 22 (Scheme 3). Exposure of ketone 22 to a Brown asymmetric methallylation delivered
the tertiary alcohol 23 in excellent yield with a 10:1 diastereoselectivity. Cleavage of the PMB
ether then produced the required allylic alcohol 24. The allylic alcohol 24 was processed under
standard Sharpless conditions leading to in situ formation of the desired tetrahydrofuran ring.
Oxidative cleavage of the product diol and subsequent reduction of the intermediate aldehyde
gave the alcohol 25. Unfortunately, unlike diene 20, ring-closing metathesis could not be
induced using diene 25 and a variety of similar analogs to produce the oxocene 26. This
disappointing turn of events led to a reevaluation of the strategy for the B ring synthesis and
led to the investigation of alternative routes.
In our revised approach to the B ring, we hoped to incorporate the C8 methyl group after the
formation of the oxocene (Figure 2). To accommodate this approach we anticipated that a
temporary, removable tether would be required to facilitate the ring-closing metathesis. Rather
than use a glycolate alkylation and Brown allylation to establish the C8 and C9 stereocenters
in separate steps, we hoped to employ a glycolate aldol reaction to introduce both centers
stereoselectively in a single transformation.[18] This would also allow the incorporation of a
1,3-diol that could be used to introduce the required temporary tether.
The chlorotitanium enolate of previously prepared glycolate 11 was treated with 3-methyl-3-
butenal to afford the desired syn product 28 in approximately 70% yield (Scheme 4). Reduction
of the chiral auxiliary and formation of the cyclohexylidene acetal provided diene 29. With the
cyclic constraint in place, ring-closing metathesis provided the oxocene 30 in 83% yield.
[8a,b] Replacement of the benzyl ether with a t-butyldimethylsilyl ether that would be
compatible with the reduction of the olefin was accomplished in two straightforward
operations. Stereoselective hydrogenation of the C5–C6 alkene was needed to establish the C6
methyl-bearing stereocenter, but unfortunately the trisubstituted olefin of oxocene 31 was
unreactive under a variety of standard hydrogenation conditions.[19] Removal of the
cyclohexylidene acetal provided diol 32, which was also unreactive toward reductive
conditions, including attempted hydrogenation using the homogeneous Crabtree's catalyst.
[20] Postulating that the steric encumbrance of the silyl protecting groups was deterring the
reduction of the olefin, the silyl ethers were replaced with a cyclohexylidene acetal to deliver
oxocene 33 in three routine steps. Indeed, hydrogenation of oxocene 33 was possible in the
presence of Pearlman's catalyst, at elevated pressure, providing the targeted oxocane 34 in 90%
yield; however, the cyclohexylidene acetal was cleaved during this process, and the oxocane
was isolated as a 1:1 diastereomeric mixture of epimers at C6. It was clear that a new strategy
needed to be implemented for the B ring allowing for stereoselective establishment of C6 and
the tertiary alcohol at C8 present in brevetoxin A (1).
At this stage, we adopted a third generation approach to the B ring that utilized the anti-
glycolate aldol methodology that we had recently developed.[21] The chlorotitanium enolate
of allyloxy glycolylimide 35 was treated with 3-methyl-3-butenal to provide the alcohol 36 in
64% yield and 9:1 dr, favoring the desired anti adduct (Scheme 5).[6c] Removal of the chiral
auxiliary and sequential protection of the resultant diol provided diene 37. The allyl protecting
group was selectively removed in the presence of the 1,1-disubstituted olefin,[22] and the
resultant alcohol was transformed to the glycolate 38 via the glycolic acid. Alkylation of the
sodium enolate of glycolate 38 with benzyl iodomethyl ether (generated in situ from
(BnO)2CH2 and TMSI) proceeded in 93% yield, and reduction of the oxazolidinone moiety
delivered alcohol 39.[9] Oxidation[12] of the primary alcohol followed by addition of
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vinylmagnesium bromide gave dienes 40 and 41 in a 3:1 diastereomeric ratio. Ring-closing
metathesis using the Grubbs second generation catalyst was possible in the absence of a cyclic
constraint to produce oxocenes 42 and 43,[8a,b] which were separable at this stage. The minor
component 42 of this mixture was transformed to the desired oxocene 43 via a Mitsunobu
inversion.[23] Crabtree's catalyst proved remarkably effective for the reduction of the
trisubstituted olefin of oxocene 43,[20] providing the oxocane 44 and its C6 epimer in a 3:1
ratio at 25 °C, 8:1 at −20 °C and a >19:1 ratio (93% yield) at −50 °C. The allylic hydroxyl
effectively directs the hydrogenation of the C6–C7 alkene to the opposite face of the ring.
Similar effects are observed in the directed Simmons–Smith cyclopropanation and directed
epoxidation of cyclooctenol.[24,25] Next, oxidation[26] of the C8 hydroxyl and subsequent
treatment of the ensuing ketone with methylmagnesium chloride provided the tertiary alcohol
45 in excellent yield and high diastereoselectivity (>19:1 dr).[27] The benzyl ether of oxocane
45 was reductively removed[28] in the presence of the more electron rich PMB ether to afford
the primary alcohol, which was oxidized[26] to deliver the targeted B ring aldehyde 46.
Much had been learned regarding the required functionality to facilitate the ring-closing
metathesis and hydrogenation of the B ring during the course of our studies. However, while
a viable approach to B ring aldehyde 46 was in place, a final improvement to this route was
needed. Installation of C1 at an early stage of the synthesis was desired to obviate the need for
a late-stage homologation at C2 of the B ring.
For the homologated B ring 47, we envisioned the installation of C1 through a Claisen addition,
and planned to then intercept the previous strategy prior to the glycolate alkylation (Figure 3).
[6a] This would take advantage of the directed reduction of the C6–C7 double bond as before,
and utilize the basic strategy for the construction of the oxocene and incorporation of the C8
methyl group from the third generation route.
The sodium enolate of p-methoxybenzyloxy glycolylimide 49 was alkylated with methallyl
iodide[9] and the resultant product 50 underwent an unprecedented Claisen condensation with
the lithium enolate of ethyl acetate to afford the β-keto ester 51 directly (Scheme 6).[29]
Exhaustive reduction with lithium aluminum hydride followed by selective protection of the
primary alcohol as its TIPS ether, and finally oxidation[12] of the secondary alcohol provided
ketone 52.[30] Chelation-controlled reduction of ketone 52 mediated by Zn(BH4)2 delivered
the targeted one-carbon homologated secondary alcohol 53.[31] From this point, a similar
sequence of transformations to those previously developed, with optimizations for large scale
throughput, were employed. Glycolate 48 was prepared under standard conditions from alcohol
53, and the alkylation of imide 48 with benzyl iodomethyl ether proceeded efficiently.[9]
Reduction of the alkylation product afforded alcohol 54, which was oxidized to the
corresponding aldehyde.[12] The aldehyde was exposed to vinylmagnesium bromide
whereupon ring-closing metathesis again gave a mixture of oxocenes 55 and 56 (3:1 dr) in just
2 h. Minor oxocene 56 was converted to the desired oxocene 55 via Swern oxidation and Luche
reduction.[32] Hydrogenation of the allylic alcohol 55 with Crabtree's catalyst at −50 °C
provided the oxocane in 94% yield (>19:1 dr).[20] Oxidation[12] of the C8 alcohol and addition
of methylmagnesium chloride to the resultant ketone gave alcohol 57 as a single observable
diastereomer. Removal of the benzyl ether using Raney nickel,[33] and oxidation[26] of the
primary alcohol delivered the desired homologated B-ring aldehyde 6 in 81% yield over two
steps. As a testament to the scalability of this route, >3 g of aldehyde 6 were prepared via this
sequence in a single execution of the synthetic sequence.
Synthesis of the E Ring
The initial synthesis of the E ring fragment 58 was predicated upon a glycolate alkylation[9]
and ring-closing metathesis strategy to prepare the functionalized oxonene (Figure 4).[10] An
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asymmetric glycolate alkylation and a thiazolidinethione-mediated aldol addition were
envisioned to establish three of the required stereocenters of the acyclic diene precursor.
Alkylation of the sodium enolate of glycolate 60 with allyl iodide, reduction to the primary
alcohol, and oxidation under Swern conditions afforded aldehyde 61 (Scheme 7).[12] Addition
of aldehyde 61 to the chlorotitanium enolate of oxazolidinethione propionate 62 provided the
aldol adduct 59 as a single detectable diastereomer by 1H NMR.[34] Subsequent reductive
removal of the chiral auxiliary provided a 1,3-diol, which underwent selective protection of
the primary alcohol as its TIPS ether to give secondary alcohol 63. Alkylation of the secondary
alcohol with sodium bromoacetate provided the corresponding glycolic acid derivative, which
was converted to its mixed pivaloyl anhydride and exposed to (R)-5-lithio-4-isopropyl-
oxazolidin-2-one to produce the required glycolyl oxazolidinone 64. The C22 stereocenter was
established by alkylation of the glycolyl oxazolidinone with prenyl iodide under standard
conditions[9] to provide imide 65. Reduction of the oxazolidinone gave a primary alcohol
which was oxidized[12] to the aldehyde 66. Brown allylation[13] of aldehyde 66 gave a triene
in 89% yield as a single detectable diastereomer, and acetylation of the secondary alcohol
afforded acetate 67. The trisubstituted olefin 67 was selectively epoxidized followed by
exposure of the resultant diene to the Grubbs catalyst [Cl2(Cy3P)2Ru=CHPh] to effect ring-
closing metathesis, which generated the oxonene 68 in 99% yield.[7] The epoxide was exposed
to aqueous perchloric acid resulting in hydrolytic opening of the epoxde accompanied by partial
cleavage of the primary silyl ether,[35] requiring conversion back to the TIPS ether. Oxidative
cleavage of the 1,2-diol provided aldehyde 69. Simultaneous reduction of the aldehyde and the
acetate with LiAlH4, protection of the resultant diol as the dibenzyl ether, and cleavage of the
silyl ether realized the desired E ring 70 in 96% yield.
While a viable strategy for synthesis of the E ring had been developed, we hoped to improve
the protecting group strategy and eliminate the need for the somewhat cumbersome oxidative
cleavage of the prenyl substituent as a latent oxygen functionality. As previously demonstrated
in the B ring synthesis (vide supra, Scheme 5), the anti-glycolate aldol reaction developed in
our laboratory is a useful means for generating anti-1,2-diol units, which are commonly found
in ladder ether toxins.[21,6c] To that end, previously described alcohol 63 was transformed to
the oxazolidinethione glycolate 71 (Scheme 8). The chlorotitanium enolate of glycolate 71
underwent an aldol reaction with 3-butenal in 50% yield (89% brsm) and 5:1 dr to provide the
aldol adduct 72.[21] Reduction of the oxazolidinethione moiety gave alcohol 73. At this stage,
the benzyl ether was cleaved with sodium naphthalenide, and the resultant triol was protected
as the tris-p-methoxybenzyl ether. Tetrabutylammonium fluoride-mediated removal of the
primary silyl group gave alcohol 74. Although this sequence had led to the diene 74 in a shorter
sequence of transformations, the subunit was lacking C24, which had been present in our
previous synthesis. Hoping to achieve a more practical synthesis of a homologated E ring, we
once again revised our approach to this medium ring ether.
In the final plan for the E ring, as with the B ring (vide supra, Scheme 6), we hoped to
incorporate all of the carbons of the E ring from the outset, avoiding the need for a late-stage
homologation. Our third generation approach to the E ring[6a] commenced with an alkylation
of the sodium enolate of glycolate 49[9] with allyl iodide, followed by reductive removal of
the oxazolidinone and oxidation of the resultant primary alcohol to deliver aldehyde 75
(Scheme 9).[12] A syn-aldol addition between the chlorotitanium enolate of (R)-N-
propionyl-4-benzylthiazolidin-2-thione (62) and aldehyde 75 proceeded efficiently, generating
the aldol adduct 76. Exposure of the aldol adduct 76 to sodium borohydride gave a diol, which
upon selective protection of the primary alcohol delivered the secondary alcohol 77. Formation
of the glycolic acid and subsequent conversion to the corresponding imide 78 set the stage for
alkylation with bromoacetonitrile to diastereoselectively establish the C22 stereocenter.[9]
Removal of the auxiliary under reductive conditions then provided alcohol 79 in 75% yield for
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two steps. Oxidation[12] of alcohol 79 to the aldehyde preceded a substrate-controlled
stereoselective allylation to afford diene 80 in 80% yield (7:1 dr).[36,37] Treatment of diene
80 with hydrochloric acid at 65 °C in methanol served to hydrolyze the nitrile to the carboxylic
acid, which formed the γ-lactone in situ, and also cleaved the silyl and p-methoxybenzyl ethers
in a single operation in 85% yield. The resultant diol was protected as the bis-TBS ether to
give lactone 81. The lactone 81 was reduced with lithium aluminum hydride, whereupon the
resulting diol was transformed to the dibenzyl ether. Selective deprotection of the primary silyl
ether provided the targeted diene 7, with C24 in place.[38]
Synthesis of the G Ring
The first generation synthesis of the G ring was inspired by the initial success of the asymmetric
glycolate alkylation/aldol/ring-closing metathesis approach to the E ring. In the case of the G
ring (82, Figure 5), either an asymmetric aldol or glycolate alkylation could potentially be used
to set the C26 stereocenter. Additionally, a latent C–O bond at C34 would be masked through
the regioselective epoxidation of a triene intermediate, followed by ring-closing metathesis.
Thus, a key intermediate would be a complex glycolyl oxazolidinone 83, with the stereocenter
at C32 envisioned to arise from a Sharpless kinetic resolution.
To investigate this approach, the glycolyl oxazolidinone 83 (Scheme 10) was pursued,
beginning with the addition of allyl Grignard to methacrolein (84). Resolution of the resulting
racemic mixture of secondary alcohols 85 through a Sharpless kinetic resolution provided
epoxy alcohol 86 (98% ee at 43% conversion),[11b] which was protected as the benzyl ether
87. Copper-assisted Grignard addition to form the secondary alcohol 88, followed by O-
alkylation with sodium bromoacetate, produced glycolic acid 89. The glycolic acid was first
coupled to (S)-4-benzyl-2-oxazolidinone to examine the aldol addition of the chlorotitanium
enolate of imide 84a with acrolein, which would install both the C26 stereocenter and the olefin
required for subsequent ring-closing metathesis. Despite efforts toward optimization, only a
25% yield of the desired aldol adduct 90 could be obtained.
On the other hand, coupling of glycolic acid 89 with (S)-4-isopropyl-2-oxazolidinone allowed
for the efficient alkylation of imide 84b with BnOCH2I to provide alkylation product 91.[9]
Reductive removal of the auxiliary with NaBH4 generated the primary alcohol, which
underwent oxidation under Dess–Martin conditions to afford aldehyde 92. Addition of
vinylmagnesium bromide to the aldehyde gave an 80% yield of the triene as mixture of
diastereomers, and selective epoxidation of the trisubstituted olefin with m-chloroperbenzoic
acid furnished epoxy diene 93. Treatment of diene 93 with Grubbs' second generation catalyst
then led to an 85% yield of oxocene 83.[8a,b] Attempts to perform the ring-closing metathesis
with Grubbs' first generation catalyst led to a lower yield (50%).
The first generation synthesis of the G ring provided a preliminary route to an important
intermediate in the brevetoxin synthesis, and further demonstrated the utility of the glycolate
alkylation/ring-closing metathesis approach. However, the multigram quantities of G ring
needed for further development of the total synthesis motivated the investigation of a second
generation route optimized for scale-up. In particular, a chelation-controlled Grignard addition
leading to N-glycolyl oxazolidinone 95 was envisioned as being a more efficient alternative to
the Sharpless kinetic resolution for installation of the C32 stereocenter (Figure 6).
The second generation route to the G ring commenced with an asymmetric alkylation of imide
ent-48 (Scheme 11) with allyl iodide.[9] In an earlier report,[6b] the alkylation product 96 was
treated with LiBH4 for reductive removal of the auxiliary, and the resultant alcohol was
oxidized under Swern conditions to the corresponding aldehyde ent-75. Addition of lithiated
tBuOAc to aldehyde ent-75 provided alcohols 97 as an inconsequential mixture of
diastereomers, and exposure to LiAlH4 led to diols 98. While this five step sequence was high
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yielding overall, our observation from the B ring synthesis that N-glycolyl oxazolidinones
readily participate in Claisen addition reactions with lithiated esters provided a means to
streamline the preparation of diols 98 (vide supra, Scheme 6).[6a] The addition of the lithium
enolate of tBuOAc to alkylation product 96 proceeded smoothly to produce β-ketoester 99 in
85% yield. The reduction of β-ketoester 99 with LiAlH4 was complicated somewhat by the
presence of enol tautomers, which led to enolate intermediates resistant to reduction.
Nonetheless, a 67% yield of diols 98 based on recovered starting material was reproducible.
Upon selective protection of the primary alcohol of diols 98 as the TIPS ether and oxidation
to the ketone under Swern conditions (Scheme 12), the chelation-controlled addition of
methylmagnesium chloride to the ketone 100 afforded tertiary alcohol 101 as a single isomer
in excellent yield. After O-alkylation with sodium bromoacetate and coupling of the resulting
glycolic acid with (S)-4-isopropyl-2-oxazolidinone, alkylation of the N-acyloxazolidinone
102 with BnOCH2I once again performed well, even on larger scale: over 100 g of alkylation
product 103 have been prepared.
Similar to before, reductive removal of the chiral auxiliary from alkylation product 103,
oxidation of the resulting alcohol under Swern conditions, and addition of vinylmagnesium
bromide to the aldehyde 104 provided the allylic alcohols as a mixture of diastereomers.
Subsequent exposure of the diene to Grubbs' second generation catalyst furnished the oxocene
94 in high yield at up to 10 mM concentration.[8a,b]
To properly functionalize the G ring, we had originally reported[6b,d] the use of Crabtree's
catalyst[20] under H2 atmosphere for the hydrogenation of the endocyclic olefin. However,
upon scale-up, these conditions led to a somewhat disappointing 70% yield of the desired
oxocanes 105, with loss of the PMB protecting group and epimerization at C26 via alkene
isomerization accounting for undesirable portions of the mass balance. Alternatively,
hydrogenation with o-NO2C6H4SO2NHNH2[39] and Et3N was found to cleanly afford the
oxocanes 105 in 96% yield without any significant side reactions. For convergence of the C27
diastereomers, oxidation to the ketone under Swern conditions followed by treatment with
iBu2AlH provided the alcohol 8 as a single isomer. This completed the second generation
synthesis of G ring intermediate 8 in 16 steps, with an overall yield of 12%.
Synthesis of the J Ring
In formulating a synthetic plan for the J ring 106, it was reasoned that a ring-closing metathesis
approach would be particularly germane since the dihydropyran produced would be the
required substrate for dihydroxylation to install the necessary syn diol (Figure 7). In our initial
approach to the diene substrate 107 for ring-closing metathesis, an asymmetric acetate aldol
and a glycolate alkylation were envisioned as key stereo-determining and C–C bond-forming
steps.
The original route to the J ring drew upon interest in our laboratory on aldol reactions involving
the titanium enolates of N-acetylthiazolidinethione auxiliaries. Though we have recently shown
that the mesityl-substituted auxiliary of this type undergoes aldol reaction with a variety of
aldehydes in high yield and stereoselectivity,[40] at the outset of the J ring synthesis, the
isobutyl-substituted N-acetylthiazolidinethione auxiliary was known to provide reasonable
selectivity levels via the Urpí protocol, particularly with α,β-unsaturated aldehydes.[10b,41]
Specifically, the aldol reaction of N-acetylthiazolidinethione 108 (Scheme 13) with trans-
cinnamaldehyde led to a 76% yield of the major aldol adduct 109a (90:10 dr). Because the
olefin installed in the aldol reaction would undergo a ring-closing metathesis, the phenyl
substituent on the olefin was inconsequential. Reductive removal of the auxiliary with
NaBH4 and selective protection of the resultant primary alcohol 110a produced the TIPS ether
111a. After O-alkylation of the secondary alcohol with sodium bromoacetate and coupling of
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the corresponding glycolic acid to (R)-4-isopropyl-2-oxazolidinone, the alkylation of imide
112a was attempted.[9] Unfortunately, alkylation with allyl iodide took place in only a 28%
yield, with the major side-reaction involving 2,3-Wittig rearrangement of the sodium enolate.
[42]
To circumvent the low yield of the glycolate alkylation, it was hypothesized that replacement
of the phenyl group on the olefin with an aliphatic chain would reduce the rate of the competing
2,3-Wittig rearrangement. To this end, trans-2-hexenal was used as the aldehyde in the acetate
aldol reaction (108 to 109b, Scheme 13). In this case, a 64% yield of the aldol adduct was
obtained, with a slightly diminished diastereoselectivity (7:1). After the same four step
sequence as before, the glycolate alkylation was attempted once again. Pleasingly, a 90% yield
of the alkylation product 113b was obtained.
Conversion of alkylation product 113b to J ring 107 was then accomplished in four additional
steps. Upon reductive removal of the chiral auxiliary, the resulting primary alcohol was
protected as the benzyl ether 114. As expected, ring-closing metathesis with Grubbs' catalyst
afforded the dihydropyran in excellent yield,[8] and Upjohn dihydroxylation[43] occurred in
78% overall yield with a diastereoselectivity of 3:l to produce J ring 106. The facial bias is
presumably imparted by the bulky TIPS group. Alternatively, the Sharpless asymmetric
dihydroxylation protocol[44] gave slightly improved selectivity (4:1), but in only 60% overall
yield.
The first generation approach to the J ring confirmed the effectiveness of the ring-closing
metathesis/dihydroxylation sequence for completing the ring core, but was limited in terms of
throughput by the moderate yield and tedious separation of diastereomers associated with the
acetate aldol. Furthermore, the C43 and C44 carbons would need to be added through
subsequent manipulations, further lengthening the synthesis. Thus, a second generation
synthesis targeting a J ring 115 possessing the C42–C44 side chain was formulated (Figure 8).
It was also postulated that the acetate aldol and glycolate alkylation steps could be replaced by
an epoxide-opening and a Hosomi–Sakurai reaction, respectively. This approach would
involve a mixed acetal intermediate 116, which could be rapidly prepared through
transacetalization.
To begin the second generation synthesis of the J ring, known alcohol 118[45] was prepared
in two steps from (R)-glycidol (117) (Scheme 14). The smooth conversion of alcohol 118 to
mixed acetal 116 was then accomplished through a transacetalization reaction under mild
conditions. Ring-closing metathesis with the Grubbs catalyst proceeded in excellent yield as
before, and the resulting dihydropyran was dihydroxylated stereoselectively with the RuCl3/
NaIO4 oxidation system (8:1 dr),[46] with the bulky silyl protecting group once again providing
the presumed facial bias. Protection of the diol 119 as the carbonate using 1,1′-
carbonyldiimidazole (CDI) preceded the key Hosomi–Sakurai reaction,[47] which delivered
pyran 121 in good yield and high diastereoselectivity (dr >10:1) via putative transition state
120. Anticipating the need for a more robust diol protecting group, the carbonate group was
removed under basic conditions, and the diol was re-protected as the acetonide 122.
Hydroboration of the terminal olefin with 9-BBN then delivered the primary alcohol 115
exclusively. In testament to the scalability of this route, over 21 g of alcohol 115 was prepared
through this sequence.
Conclusion
In summary, scalable approaches to the B, E, G, and J rings of brevetoxin A have been
developed, allowing the preparation of multi-gram quantities of each of these oxacycles. Ring-
closing metathesis was utilized in each case for the cyclization event from the corresponding
Crimmins et al. Page 8













acyclic diene. Enolate methodologies developed in our laboratory were exploited to introduce
eight of the 22 stereocenters present within brevetoxin A. The routes described have proven
suitable for supplying sufficient quantities of the B, E, G, and J rings to support our efforts
toward a highly convergent synthesis of the decacyclic natural product, the completion of which
[48] is reported in the accompanying manuscript.[7]
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Refer to Web version on PubMed Central for supplementary material.
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Initial retrosynthetic analysis of the B ring 10.
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Aldol-based retrosynthetic analysis of the B ring 27.
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Key features of the strategy for the B ring 47.
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Key strategic elements for the E ring synthesis.
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Key features of the first generation synthesis of the G ring 82.
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Key features of the second generation synthesis of the G ring.
Crimmins et al. Page 17














Key features of the first generation synthesis of the J ring 106.
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Key features of the second generation synthesis of the J ring 115.
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First generation B ring synthesis. Reagents and conditions: a) (+)-DIPT, Ti(O-iPr)4, tBuOOH,
CH2Cl2, 4 Å MS, −20 °C, 63%; b) NaH, BnBr, nBu4NI, THF, 91%; c) KCN, LiClO4,
CH3CN, 80 °C, 84%; d) NaOH, H2O, MeOH, 65 °C; e) LiAlH4, Et2O, 35 °C, 78% for 2 steps;
f) TIPSCl, imid., DMF, 89%; g) NaH, BrCH2CO2H, THF, 88%; h) PivCl, Et3N, (R)-5-lithio-4-
isopropyl-oxazolidin-2-one, THF, 80%; i) NaN(SiMe3)2, E-ICH2CH=CHCH2OPMB (16),
THF, PhMe, −78 to −45 °C, 80%; j) LiBH4, MeOH, Et2O, 0 °C, 96%; k) (COCl)2, DMSO,
Et3N, CH2Cl2; l) (4-dIcr)2BCH2C(Me)=CH2, Et2O, THF, −78 °C, 94% for 2 steps; m) Ac2O,
pyr., DMAP, CH2Cl2, 92%; n) DDQ, H2O, CH2Cl2, 0 °C, 85%; o) (+)-DET, Ti(O-iPr)4,
tBuOOH, CH2Cl2, 4 Å MS, −20 °C, 93%; p) K2CO3, MeOH, Et2O, 89%; q) NaIO4, THF,
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H2O; r) NaBH4, EtOH, 0 °C, 92% for 2 steps; s) Cl2(Cy3P)(IMes)Ru=CHPh, CH2Cl2, 40 °C,
70%.
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Attempted incorporation of the C8 methyl. Reagents and conditions: a) LiBH4, MeOH, Et2O,
0 °C, 96%; b) (COCl)2, DMSO, Et3N, CH2Cl2; c) MeMgI, Et2O, 0 °C, 90%; d) (COCl)2,
DMSO, Et3N, CH2Cl2; e) (4-dIcr)2BCH2C(Me)=CH2, Et2O, THF, −78 °C, 89% for 2 steps,
10:1 dr; f) DDQ, H2O, CH2Cl2, 0 °C, 85%; g) (+)-DET, Ti(O-iPr)4, tBuOOH, CH2Cl2, 4 Å
MS, −20 °C, 93%; h) NaIO4, THF, H2O; i) NaBH4, EtOH, 0 °C, 92% for 2 steps; j)
Cl2(Cy3P)(IMes)Ru=CHPh, CH2Cl2, 40 °C, no reaction.
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Second generation B ring synthesis. Reagents and conditions: a) TiCl4, iPr2NEt, CH2=C(Me)
CH2CHO, CH2Cl2, −78 °C; b) LiBH4, MeOH, Et2O, 0 °C, 58% for 2 steps; c) cyclohexanone,
PPTS, MgSO4, C6H6, 80 °C, 87%; d) Cl2(Cy3P)(IMes)Ru=CHPh, CH2Cl2, 40 °C, 83%; e)
Na, naphthalene, THF, 0 °C, 91%; f) TBSOTf, 2,6-lut., CH2Cl2, 90%; g) PPTS, EtOH, 78 °C,
72%; h) Ac2O, DMAP, CH2Cl2, 87%; i) nBu4NF, THF, 100%; j) cyclohexanone, PPTS,
MgSO4, C6H6, 80 °C, 94%; k) Pd(OH)2/C, H2 (45 psi), EtOH, 90%, 1:1 dr.
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First stereocontrolled completion of the B ring 46. Reagents and conditions: a) TiCl4, (−)-
sparteine, CH2=C(Me)CH2CHO, CH2Cl2, −78 °C, 64%, 9:1 dr; b) LiBH4, MeOH, Et2O, 0 °
C, 78%; c) TIPSCl, imid., DMF, 95%; d) PMBBr, NaH, DMF, 86%; e) Ti(O-iPr)4, nBuMgCl,
Et2O, 0 °C, 86%; f) NaH, BrCH2CO2H, THF, DMF, 91%; g) PivCl, Et3N, (R)-5-lithio-4-
isopropyl-oxazolidin-2-one, THF, 90%; h) NaN(SiMe3)2, (BnO)2CH2, TMSI, THF, −78 °C,
93%; i) LiBH4, MeOH, Et2O, 0 °C, 81%; j) (COCl)2, DMSO, Et3N, CH2Cl2; k)
CH2=CHMgBr, THF, 0 °C, 76% for 2 steps, 3:1 dr; l) Cl2(Cy3P)(IMes)Ru=CHPh, CH2Cl2,
40 °C, 75%; m) [PCy3] [COD] [pyr]Ir+PF6-, H2, CH2Cl2, −50 °C, 93%; n) Dess–Martin
periodinane, CH2Cl2, 89%; o) MeMgCl, Et2O, −78 °C, 89%; p) LiDBB, THF, −78 °C, 98%;
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q) Dess–Martin periodinane, CH2Cl2, 88%; r) PPh3, p-NO2C6H4CO2H, DEAD, C6H6;
iBu2AlH, CH2Cl2, −78 °C, 50% for 2 steps.
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Homologated B ring synthesis. Reagents and conditions: a) NaN(SiMe3)2, CH2=C(Me)CH2I,
THF, −78 °C, 78%; b) LDA, EtOAc, THF, −78 °C, 84%; c) LiAlH4, Et2O, 0 °C, 80%; d)
TIPSCl, imid., CH2Cl2, 100%; e) (COCl)2, DMSO, Et3N, CH2Cl2, 100%; f) Zn(BH4)2, Et2O,
−25 °C, 79%; g) NaH, BrCH2CO2H, THF, DMF, 90%; h) PivCl, Et3N, (R)-5-lithio-4-
isopropyl-oxazolidin-2-one, THF, 90%; i) NaN(SiMe3)2, (BnO)2CH2, TMSI, THF, −78 °C,
83%; j) LiBH4, MeOH, Et2O, 0 °C, 86%; k) (COCl)2, DMSO, Et3N, CH2Cl2, 99%; l)
CH2=CHMgBr, THF, 0 °C, 86% (3:1 dr); m) Cl2(Cy3P)(IMes)Ru=CHPh, CH2Cl2, 40 °C,
71%; n) [PCy3] [COD] [pyr]Ir+PF6-, H2, CH2Cl2, −50 °C, 94%; o) (COCl)2, DMSO, Et3N,
CH2Cl2, 95%; p) MeMgCl, Et2O, −78 °C, 88%; q) Raney Ni, H2, EtOH, 95%; r) Dess–Martin
periodinane, CH2Cl2, 85%; s) (COCl)2, DMSO, Et3N, CH2Cl2, 64%; t) CeCl3•7H2O,
NaBH4, MeOH, 82%.
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Initial E ring synthesis. Reagents and conditions: a) NaN(SiMe3)2, CH2=CHCH2I, THF, −78
°C, 82%; b) NaBH4, H2O, THF, 95%; c) (COCl)2, DMSO, Et3N, CH2Cl2; d) Propionate 62,
TiCl4, (−)-sparteine, NMP, CH2Cl2, 92% for 2 steps; e) LiBH4, MeOH, Et2O, 0 °C, 91%; f)
TIPSCl, imid., DMF, 70 °C, 96%; g) NaH, BrCH2CO2H, THF, 81%; h) PivCl, Et3N, (R)-5-
lithio-4-isopropyl-oxazolidin-2-one, THF, 77%; i) NaN(SiMe3)2, (Me)2C=CHCH2I, −78 °C,
83%; j) LiBH4, MeOH, Et2O, 0 °C, 87%; k) (COCl)2, DMSO, Et3N, CH2Cl2; l)
(2-dIcr)2BCH2CH=CH2, Et2O, THF, −78 °C, 89% for 2 steps; m) Ac2O, Et3N, DMAP,
CH2Cl2, 96%; n) m-CPBA, CH2Cl2, −20 °C, 97%; o) Cl2(PCy3)Ru=CHPh, CH2Cl2, 40 °C,
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99%; p) HClO4, H2O, THF, 59%; q) NaIO4, nBu4NHSO4, THF, H2O, 92%; r) LiAlH4, Et2O,
0 °C, 96%; s) NaH, BnBr, DMF, THF, 40 °C, 75%; t) nBu4NF, THF, 96%.
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Second generation E ring synthesis. Reagents and conditions: a) NaH, BrCH2CO2H, THF,
81%; b) PivCl, Et3N, (S)-5-lithio-4-benzyl-2-oxazolidinethione, THF, 66%; c) TiCl4, (−)-
sparteine, CH2=CHCH2CHO, CH2Cl2, −78 °C, 50% (5:1 dr), 89% brsm; d) LiBH4, MeOH,
Et2O, 0 °C, 80%; e) Na, naphthalene, THF, 0 °C, 98%; f) NaH, PMBBr, DMF; g) nBu4NF,
THF, 90% for 2 steps.
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Third generation E ring synthesis. Reagents and conditions: a) NaN(SiMe3)2, CH2=CHCH2I ,
THF, −78 °C, 76%; b) NaBH4, H2O, THF, 93%; c) (COCl)2, DMSO, Et3N, CH2Cl2; d)
Propionate 62, TiCl4, (−)-sparteine, NMP, CH2Cl2; e) NaBH4, H2O, THF, 78% for 3 steps; f)
TIPSCl, imid., CH2Cl2, 97%; g) NaH, BrCH2CO2H, THF, DMF, 92%; h) PivCl, Et3N, (R)-5-
lithio-4-isopropyl-oxazolidin-2-one, THF, 89%; i) NaN(SiMe3)2, BrCH2CN, −78 °C; j)
NaBH4, H2O, THF, 75% for 2 steps; k) (COCl)2, DMSO, Et3N, CH2Cl2; l)
CH2=CHCH2SnBu3, AlMe3, CH2Cl2, −78 °C; m) HCl, MeOH, 65 °C, 69% for 3 steps; n)
TBSCl, imid., DMF, 80 °C, 80%; o) LiAlH4, Et2O, −20 °C, 88%; p) NaH, BnBr, DMF, 98%;
q) HF•pyr, THF, 72%.
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First generation synthesis of the G ring 82. Reagents and conditions: a) CH2=CHCH2MgBr,
Et2O, 35 °C, 80%; b) (−)-DCHT, Ti(iPrO)4, tBuOOH, 4Å mol. sieves, CH2Cl2, −20 °C, 43%
(98% ee); c) BnBr, NaH, THF, 87%; d) Me2C=CHMgBr, CuI, THF, 86%; e) BrCH2CO2H,
NaH, THF, 87%; f) PivCl, Et3N, THF; then (S)-5-lithio-4-benzyl-2-oxazolidinone (R1= Bn)
or (S)-5-lithio-4-isopropyl-2-oxazolidinone (R1= iPr), −78 to 0 °C, 80% or 85% respectively;
g) TiCl4, (−)-sparteine, acrolein, CH2Cl2, -78 to 0 °C, 25%; h) NaN(SiMe3)2, (BnO)2CH2,
TMSI, THF, −78 to -45 °C, 70%; i) NaBH4, THF, H2O, 88%; j) Dess–Martin periodinane,
CH2Cl2; k) CH2=CHMgBr, THF, −78 °C, 80% (2 steps); l) m-CPBA, CH2Cl2, −20 °C, 80%;
m) Cl2(PCy3)(sIMes)Ru=CHPh, CH2Cl2, 40 °C, 85%.
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Preparation of Diols 98. Reagents and conditions: a) NaN(SiMe3)2, CH2=CHCH2I, THF, -78
to -45 °C, 80%; b) LiBH4, MeOH, Et2O, 0 °C, 90%; c) (COCl)2, DMSO, Et3N, CH2Cl2, −78
to 0 °C, 97%; d) tBuO2CCH2Li, THF, −78 °C, 85% from 96, 75% from ent-75; e) LiAlH4,
Et2O, 0 °C, 92% from 97, 67% from 99 brsm.
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Second generation synthesis of the G ring 8. Reagents and conditions: a) TIPSCl, imid.,
CH2Cl2, 99%; b) (COCl)2, DMSO, DIEA, CH2Cl2, −78 to 0 °C, 94%; c) MeMgCl, Et2O, -78
°C, 97%; d) BrCH2CO2H, NaH, DMF, 30 h, 84% (after 1 recycle); e) PivCl, Et3N, THF; then
(S)-5-lithio-4-isopropyl-2-oxazolidinone, -78 to 0 °C, 86%; f) NaN(SiMe3)2, (BnO)2CH2,
TMSI, THF, −78 °C; g) LiBH4, MeOH, Et2O, 0 °C, 70% (2 steps); h) (COCl)2, DMSO,
Et3N, CH2Cl2, −78 to 0 °C, 99%; i) CH2=CHMgBr, THF, 0 °C, 80%; j) Cl2(PCy3)(sIMes)
Ru=CHPh, CH2Cl2, 40 °C, 85%; k) o-NO2C6H4SO2NHNH2, Et3N, DME, 85 °C, 95%; l)
(COCl)2, DMSO, Et3N, CH2Cl2, −78 to 0 °C, 96%; m) iBu2AlH, CH2Cl2, −78 °C, 98%.
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First Generation Synthesis of the J Ring 106. Reagents and conditions: a) TiCl4, DIEA,
CH2Cl2, −78 °C; then trans-cinnamaldehyde or trans-2-hexenal, 76% (dr = 10:1) or 64% (dr
= 7:1), respectively; b) NaBH4, H2O, THF, 80% (R = Ph), 82% (R = nPr); c) TIPSCl, imid.,
DMF, 92% (R = Ph), 73% (R = nPr); d) BrCH2CO2H, NaH, THF, 83% (R = Ph), 87% (R =
nPr); e) PivCl, Et3N, THF; then (R)-5-lithio-4-isopropyl-2-oxazolidinone, −78 to 0 °C, 80%
(R = Ph), 67% (R = nPr); f) NaN(SiMe3)2, CH2=CHCH2I, THF, −78 to −45 °C, 28% (R = Ph),
90% (R = nPr); g) NaBH4, H2O, THF, 86%; h) BnBr, NaH, THF, 99%; i)
Cl2(PCy3)2Ru=CHPh, CH2Cl2, 40 °C, 95%; j) OsO4, NMO, THF, H2O, 78% (dr = 3:1).
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Second generation synthesis of the J ring 115. a) TBDPSCl, imid., CH2Cl2, 0 °C to RT, 95%;
b) Me3S+I-, BuLi, THF, 0 °C, 86%; c) (EtO)2CHCH2CH=CH2, PPTS, C6H6, 60 °C, 35 mm
Hg, 87%; d) Cl2(PCy3)2Ru=CHPh, CH2Cl2, 40 °C, 95%; e) RuCl3, NaIO4, H2O, EtOAc,
CH3CN, 75%; f) CDI, THF, 65 °C, 90%; g) CH2=CHCH2SiMe3, TMSOTf, CH3CN, −10 °C,
87% (dr >10:1); h) K2CO3, MeOH, 76%; i) PPTS, (MeO)2CMe2, 92%; j) 9-BBN, THF; NaOH,
H2O2 (aq), 90%.
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